title: Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
abstract: The Financial Times Global Pharmaceutical & Biotechnology conference, held in London, included topics covering the current and future challenges confronting the pharma and biotech industry, and presented possible solutions to those challenges. This conference report highlights selected presentations on the industry challenges for big pharma companies, diversification as a solution to industry problems, overcoming challenges with collaborations and M&As, and the role of emerging markets in the pharma industry. Other subjects discussed included the expected impact of personalized medicine on the industry, the entry of big pharma into the generics market and the problems that are confronting the small pharma and biotech industry.
authors.affiliation: Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK. jennifer.scattereggia@thomsonreuters.com
authors.forename: Jennifer
authors.initials: J
authors.lastname: Scattereggia
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000191:economics / Q000458:organization & administration / Q000639:trends*; D003299:Cooperative Behavior; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration / Q000639:trends*; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D057285:Precision Medicine / Q000639:trends; D012106:Research / Q000458:organization & administration / Q000639:trends
chemical_list: D016568:Drugs, Generic